Stay updated on Savolitinib for MET Amplified Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page.

Latest updates to the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange Detected- Revision updated from v3.4.1 to v3.4.2. This appears to be a minor platform/version update that does not affect the study information or functionality presented on the page.SummaryDifference0.0%

- Check20 days agoChange DetectedFooter revision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check27 days agoChange DetectedGlossary is now shown on the page, and the metadata includes 'Last Update Submitted that Met QC Criteria'. The footer also displays 'Revision: v3.4.0' and the older phrasing 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' have been removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 was added to the page, replacing the previous v3.3.3 revision. No clinical trial content, eligibility criteria, or location details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a detailed Locations section listing state sites (CA, CT, FL, IL, KS, KY, MO, NY, NC, TX) and removed the standalone per-state location headings. Removed the HHS Vulnerability Disclosure and updated the revision to v3.3.3.SummaryDifference0.9%

- Check91 days agoChange DetectedA clarifying note was added stating that PubMed publications are automatically populated from PubMed and may not all pertain to the study. The revision version information was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Savolitinib for MET Amplified Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page.